-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
Stryker Corporation Income Statement
| Chart | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Revenue |
|
$14.35B | $17.11B | $18.45B | $20.50B |
| Cost of Revenue |
|
$5.29B | $6.14B | $6.87B | $7.40B |
| Gross Profit |
|
$9.06B | $10.97B | $11.58B | $13.10B |
| Research & Development |
|
$984.00M | $1.24B | $1.45B | $1.39B |
| Selling,General & Administrative |
|
$5.36B | $6.43B | $6.46B | $6.92B |
| Operating Expense |
|
$6.82B | $8.28B | $8.54B | $9.21B |
| Operating Income |
|
$2.22B | $2.58B | $2.84B | $3.89B |
| Net Income |
|
$1.60B | $1.99B | $2.36B | $3.17B |
Stryker Corporation Balance Sheet
| Chart | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$3.02B | $3.02B | $1.93B | $3.05B |
| Inventories |
|
$3.49B | $3.31B | $4.00B | $4.84B |
| Total Current Assets |
|
$9.71B | $10.02B | $10.28B | $12.52B |
| Property,Plant and Equipment |
|
$2.75B | $2.83B | $2.97B | $3.22B |
| Goodwill |
|
$12.78B | $12.92B | $14.88B | $15.24B |
| Total Assets |
|
$34.33B | $34.63B | $36.88B | $39.91B |
| Total Liabilities |
|
$21.25B | $19.75B | $20.27B | $21.32B |
| Retained Earnings |
|
$12.46B | $13.48B | $14.77B | $16.77B |
| Total Shareholder Equity |
|
$13.08B | $14.88B | $16.62B | $18.59B |
| Common Stock |
|
$38.00M | $38.00M | $38.00M | $38.00M |
Stryker Corporation Cash flow
| Chart | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$812.00M | $990.00M | $998.00M | $1.03B |
| Dividends Payout |
|
-$863.00M | -$950.00M | -$1.05B | -$1.14B |
| Capital Expenditures (Capex) |
|
-$487.00M | -$525.00M | -$588.00M | -$575.00M |
| Free Cash Flow (FCF) |
|
$2.79B | $2.74B | $2.04B | $3.14B |
Stryker Corporation Profitability
| Chart | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gross Profit |
|
$9.06B | $10.97B | $11.58B | $13.10B |
| Gross Profit Margin (%) |
|
63.11% | 64.11% | 62.76% | 63.89% |
| Operating Income |
|
$2.22B | $2.58B | $2.84B | $3.89B |
| Operating Income Margin (%) |
|
15.49% | 15.10% | 15.40% | 18.97% |
| Net Income |
|
$1.60B | $1.99B | $2.36B | $3.17B |
| Net Income Margin (%) |
|
11.14% | 11.66% | 12.78% | 15.44% |
| EBITDA |
|
$3.76B | $4.65B | $4.54B | $4.93B |
| EBITDA Margin (%) |
|
21.39% | 22.09% | 22.99% | 24.07% |
Stryker Corporation Ratios
| Chart | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
12.22% | 13.40% | 14.19% | 17.02% |
| Return on Assets (ROA) |
|
4.66% | 5.76% | 6.39% | 7.93% |
| Debt to Equity |
|
106.93% | 83.88% | 78.53% | 69.89% |
| Debt to total asset |
|
40.75% | 36.03% | 35.38% | 32.56% |
| Enterprise value to revenue |
|
7.13 | 6.45 | 5.62 | 6.03 |
| Enterprise value to EBITDA |
|
27.24 | 23.75 | 22.86 | 25.07 |
| Enterprise value |
|
$102.30B | $110.35B | $103.67B | $123.70B |
| Cash to Debt |
|
23.42% | 26.15% | 20.11% | 28.56% |
| Tax Rate (%) |
|
18.17% | 12.58% | 12.11% | 13.83% |
| Payout Ratio |
|
53.97% | 47.64% | 44.57% | 35.99% |
